Результати пошуку - Dejan Micić
- Показ 1 - 18 результатів із 18
-
1
-
2
-
3
-
4
-
5
Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy за авторством Dejan Micić, Yuga Komaki, Aleksandar Alavanja, David T. Rubin, Atsushi Sakuraba
Опубліковано 2017Revisão -
6
Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-α agent (infliximab), in inflammatory bowel diseases за авторством Yuga Komaki, Akihiro Yamada, Fukiko Komaki, Dejan Micić, A. Ido, Atsushi Sakuraba
Опубліковано 2017Revisão -
7
Common Variable Immunodeficiency-Like Enteropathy Associated with Rituximab B-Cell Depletion Therapy за авторством David Hakimian, Dejan Micić, Lindsay Alpert, Edwin McDonald, Carol E. Semrad
Опубліковано 2025Artigo -
8
-
9
Poor Functional Status as a Risk Factor for Severe <i>Clostridium difficile</i> Infection in Hospitalized Older Adults за авторством Krishna Rao, Dejan Micić, Elizabeth Chenoweth, Lili Deng, Andrzej T. Gałecki, Cathrin Ring, Vincent B. Young, David M. Aronoff, Preeti Malani
Опубліковано 2013Artigo -
10
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety за авторством Britt Christensen, Ruben J. Colman, Dejan Micić, Peter G. Gibson, Sarah R. Goeppinger, Andrés Yarur, Christopher R. Weber, Russell D. Cohen, David T. Rubin
Опубліковано 2018Artigo -
11
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease за авторством Britt Christensen, Peter R. Gibson, Dejan Micić, Ruben J. Colman, Sarah R. Goeppinger, Olufemi Kassim, Andrés Yarur, Christopher R. Weber, Russell D. Cohen, David T. Rubin
Опубліковано 2018Artigo -
12
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases за авторством Joana Torres, Flavio Caprioli, Κωνσταντίνος Κατσάνος, Triana Lobatón, Dejan Micić, Marco Zerôncio, Gert Van Assche, James Lee, James O. Lindsay, David T. Rubin, Remo Panaccione, Jean‐Frédéric Colombel
Опубліковано 2016Artigo -
13
The Systemic Inflammatory Response to Clostridium difficile Infection за авторством Krishna Rao, John R. Erb‐Downward, Seth T. Walk, Dejan Micić, Nicole R. Falkowski, Kavitha Santhosh, Jill A. Mogle, Cathrin Ring, Vincent B. Young, Gary B. Huffnagle, David M. Aronoff
Опубліковано 2014Artigo -
14
Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment за авторством Jonathan M. Weiss, Timothy Back, Anthony J. Scarzello, Jeff Subleski, Veronica L. Hall, Jimmy K. Stauffer, Xin Chen, Dejan Micić, Kory L. Alderson, William J. Murphy, Robert H. Wiltrout
Опубліковано 2009Artigo -
15
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel di... за авторством Britt Christensen, Dejan Micić, Peter G. Gibson, Andrés Yarur, Emanuelle Bellaguarda, Paul M. Corsello, John N. Gaetano, Jami Kinnucan, Vijaya L. Rao, S. Reddy, Siddharth Singh, Joel Pekow, David T. Rubin
Опубліковано 2018Artigo -
16
<i>Clostridium difficile</i>Ribotype 027: Relationship to Age, Detectability of Toxins A or B in Stool With Rapid Testing, Severe Infection, and Mortality за авторством Krishna Rao, Dejan Micić, Mukil Natarajan, Spencer Winters, Mark J. Kiel, Seth T. Walk, Kavitha Santhosh, Jill A. Mogle, Andrzej T. Gałecki, William LeBar, Peter Higgins, Vincent B. Young, David M. Aronoff
Опубліковано 2015Artigo -
17
Clostridium difficile Ribotype Does Not Predict Severe Infection за авторством Seth T. Walk, Dejan Micić, Ruchika Jain, Eugene Siu Kai Lo, Itishree Trivedi, Eugene Liu, Luay M. Almassalha, Sarah Ewing, Cathrin Ring, Andrzej T. Gałecki, Mary A.M. Rogers, Laraine Washer, Duane W. Newton, Preeti Malani, Vincent B. Young, David M. Aronoff
Опубліковано 2012Artigo -
18
The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients за авторством Donna Coffin, Emma Gouider, Barbara A. Konkle, Cédric Hermans, Catherine Lambert, Saliou Diop, Emily Ayoub, Ellia Tootoonchian, Toong Youttananukorn, Pamela Dakik, Ticiana Pereira, Alfonso Iorio, Glenn F. Pierce, M. Abdel Mohsen, T A Adeyemo, Gyujin Sim, Nidal Karim Al-Rahal, C. Alexis, Tauqeer Ali, Omolade Augustina Awodu, B. Aysarieva, Aznida Firzah Abdul Aziz, N. Barsallo, Abhijit Biswas, Allison Blair, Jan Blatný, Munira Borhany, D. Castillo, Cristina Catarino, Ampaiwan Chuansumrit, Minette Coetzee, Auwalu Ibrahim, Saliou Diop, A. Djenouni, A. El Ekiaby, M. El Khorassani, Kathy Fawcett, A. Ganieva, Sukanya Govindan, Dalha Haliru Gwarzo, Stifanos Hailemariam, P. Harper, Seyed Hassan Tonekaboni, Mona Hassan, Cédric Hermans, F Hernández, A. Imran, Jacob John, Bijan Keikhaei, Taiwo R. Kotila, Chong Kin Liam, Wulandewi Marhaeni, Dora Mbanya, P. Mekjarusgul, N. Meknassi, Dejan Micić, Yohannie Mlombe, R. Motusheva, Deogratias Munube, Azusa Nagao, S. Najmi, Vijayakumar Narayana Pillai, Тимур Нарбеков, Desy Aswira Nasution, Rungrote Natesirinilkul, L. Nchimba, M. N’dogomo, Daniela Neme, Philippe Nguyên, HM. Nguyen, Mi-Sa Nguyen Thi, RK. Nigam, Festus Njuguna, Theresa Ukamaka Nwagha, Asharf Obeida, Shirley Owusu‐Ofori, J. Palascak, Gaia Pellegrini, Chepsy C Philip, CL. Ping, Bishesh Sharma Poudyal, Golam Rabbani, OA. Rakoto Alson, H. Razali, Theera Ruchutrakul, Arlette Ruiz‐Sàez, Supawee Saengboon, N Salhi, Mohamed Satti, Tao Guan, Syed Imran Ali Shah, T. Shikuku, Nance Yuan, N. Sidarthan, T. Siew Looi, N. Songthawee, Darintr Sosothikul, Pacharapan Surapolchai, S.Kep Ns. Elly Suryani, NA. Syakira
Опубліковано 2023Artigo
Інструменти для пошуку:
Пов'язані теми
Medicine
Internal medicine
Disease
Gastroenterology
Inflammatory bowel disease
Immunology
Biology
Confidence interval
Ulcerative colitis
Antibiotics
Antibody
Clostridium difficile
Meta-analysis
Microbiology
Odds ratio
Economics
Observational study
Serology
Vaccination
Vedolizumab
Adverse effect
Biochemistry
Cancer
Combination therapy
Comorbidity
Coronavirus
Coronavirus disease 2019 (COVID-19)
Crohn's disease
Economic growth
Immune system